---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-111633"
form_type: "8-K"
ticker: "OVID"
cik: "0001636651"
company_name: "Ovid Therapeutics Inc."
filed_at: "2025-05-02T23:59:59+00:00"
generated_at: "2026-05-22T22:50:31.051590+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Ovid Therapeutics sets 2025 Annual Meeting for July 9; shareholder proposal deadline May 12

## Summary
- Annual Meeting scheduled for July 9, 2025; record date for voting is May 19, 2025.
- Shareholder proposals under Rule 14a-8 must be received by May 12, 2025.
- Director nominations and other proposals under bylaws also due by May 12, 2025.
- Meeting delayed more than 30 days from 2024 anniversary, triggering this 8-K notice.
- Stockholders intending to use universal proxy rules must provide Rule 14a-19 notice by May 12, 2025.

## SEC filing metadata
- accession: 0001193125-25-111633
- form_type: 8-K
- ticker: OVID
- cik: 0001636651
- company_name: Ovid Therapeutics Inc.
- filed_at: 2025-05-02T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.08
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1636651/000119312525111633/0001193125-25-111633-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1636651/000119312525111633/d830663d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-111633
- JSON: https://secwatch.observer/filing/0001193125-25-111633.json
- Plain text: https://secwatch.observer/filing/0001193125-25-111633.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.